Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome

Dig Dis Sci. 2008 May;53(5):1345-51. doi: 10.1007/s10620-007-0002-3. Epub 2007 Oct 13.

Abstract

Aim: The aim of this case-control study was to investigate both the distribution of MCP-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes.

Method: Between September 1997-January 2005, 20 patients with HPS (group 1) were compared with a group of cirrhotic patients (group 2, n = 19) as well as unrelated healthy controls (group 3, n = 59) in respect to MCP1, eNOS, tPA and PAI-1 gene polymorphism frequency distribution.

Results: MCP1-2518G allele carriage in patients with HPS was higher than in controls (P = 0.01). In non-HPS cirrhotic patients, eNOS Glu298Asp, Asp gene carriers and frequency of Asp alleles were detected to be considerably higher than in patients with HPS and healthy controls (P < 0.05).

Conclusion: HPS is more common in patients with MCP-1 2518G gene carriage; conversely it is less frequent in patients with high frequency of eNOS 298Asp allele and eNOS 298Asp carriage.

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Chemokine CCL2 / genetics*
  • Child
  • Child, Preschool
  • Female
  • Genotype
  • Hepatopulmonary Syndrome / genetics*
  • Humans
  • Infant
  • Male
  • Nitric Oxide Synthase Type III / genetics*
  • Phenotype
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Tissue Plasminogen Activator / genetics*

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • Plasminogen Activator Inhibitor 1
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Tissue Plasminogen Activator